Comparison between Sai Life Sciences IPO and Vishal Mega Mart IPO.
Sai Life Sciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Vishal Mega Mart IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Sai Life Sciences IPO is up to ₹3,042.62 Cr whereas the issue size of the Vishal Mega Mart IPO is up to ₹8,000.00 Cr. The final issue price of Sai Life Sciences IPO is ₹549.00 per share and of Vishal Mega Mart IPO is ₹78.00 per share.
| Sai Life Sciences IPO | Vishal Mega Mart IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹522.00 per share | ₹74.00 per share |
| Issue Price (Upper) | ₹549.00 per share | ₹78.00 per share |
| Issue Price (Final) | ₹549.00 per share | ₹78.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 27 shares | 190 shares |
| Fresh Issue Size | 1,73,04,189 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹950.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 3,81,16,934 shares | 1,02,56,41,025 shares |
| OFS Issue Size (Amount) | up to ₹2,092.62 Cr | up to ₹8,000.00 Cr |
| Issue Size Total | 5,54,21,123 shares | 1,02,56,41,025 shares |
| Issue Size Total (Amount) | up to ₹3,042.62 Cr | up to ₹8,000.00 Cr |
Sai Life Sciences IPO opens on Dec 11, 2024, while Vishal Mega Mart IPO opens on Dec 11, 2024. The closing date of Sai Life Sciences IPO and Vishal Mega Mart IPO is Dec 13, 2024, and Dec 13, 2024, respectively.
| Sai Life Sciences IPO | Vishal Mega Mart IPO | |
|---|---|---|
| Anchor Bid Date | Dec 10, 2024 | Dec 10, 2024 |
| Issue Open | Dec 11, 2024 | Dec 11, 2024 |
| Issue Close | Dec 13, 2024 | Dec 13, 2024 |
| Basis Of Allotment (Tentative) | Dec 16, 2024 | Dec 16, 2024 |
| Initiation of Refunds (Tentative) | Dec 17, 2024 | Dec 17, 2024 |
| Credit of Share (Tentative) | Dec 17, 2024 | Dec 17, 2024 |
| Listing date (Tentative) | Dec 18, 2024 | Dec 18, 2024 |
| Anchor Lockin End date 1 | Jan 14, 2025 | Jan 14, 2025 |
| Anchor Lockin End date 2 | Mar 15, 2025 | Mar 15, 2025 |
Sai Life Sciences IPO P/E ratio is 126.42, as compared to Vishal Mega Mart IPO P/E ratio of 76.13.
| Sai Life Sciences IPO | Vishal Mega Mart IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 41.82 | 98.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 35.24 | 76.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 126.42 | 76.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹11418.63 Cr. | ₹35168.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 11.79% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 15.96% | 68.76% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.34 | ₹1.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 8.13% | 8.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sai Life Sciences IPO Retail Individual Investors (RII) are offered 1,93,97,394 shares while in Vishal Mega Mart IPO retail investors are offered 1,93,97,394 shares. Qualified Institutional Buyers (QIB) are offered 1,10,84,224 shares in Sai Life Sciences IPO and 20,51,28,205 shares in Vishal Mega Mart IPO.
| Sai Life Sciences IPO | Vishal Mega Mart IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,66,26,336 shares | 30,76,92,307 shares |
| Market Maker Reservation | ||
| QIB | 1,10,84,224 shares | 20,51,28,205 shares |
| NII | 83,13,169 shares | 15,38,46,154 shares |
| RII | 1,93,97,394 shares | 35,89,74,359 shares |
| Employee | ||
| Others | ||
| Total | 5,54,21,123 shares | 1,02,56,41,025 shares |
Sai Life Sciences IPO subscribed 10.27x in total, whereas Vishal Mega Mart IPO subscribed 28.75x.
| Sai Life Sciences IPO | Vishal Mega Mart IPO | |
|---|---|---|
| QIB (times) | 29.78x | 85.11x |
| NII (times) | 4.99x | 15.01x |
| Big NII (times) | 6.10x | 17.34x |
| Small NII (times) | 2.78x | 10.37x |
| RII (times) | 1.39x | 2.43x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 10.27x | 28.75x |
